Huapont Life Sciences: Announcement regarding the progress of repurchasing company shares.
Huapont Life Sciences: 2023 Equity Distribution Implementation Notice
Huapont Life Sciences: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Huapont Life Sciences: 2023 Annual General Meeting of Shareholders Legal Opinions
Huapont Life Sciences: Announcement on the progress of the repurchase of company shares
Huapont Life Sciences: 002004 Huabang Health Investor Relations Management Information 20240429
Huapont Life Sciences: Announcement on preparing to accrue asset impairment
Huapont Life Sciences: The Board's Special Opinions on Evaluating the Independence of Independent Directors
Huapont Life Sciences: 2024 First Quarter Report
Huapont Life Sciences: Report on the work of the Board of Supervisors for the year 2023
Huapont Life Sciences: Announcement of Board Resolutions
Huapont Life Sciences: Announcement on the 2023 Profit Distribution Plan
Huapont Life Sciences: Announcement on the renewal of the 2024 Audit Institution
Huapont Life Sciences: Announcement on holding an online briefing on the 2023 annual results
Huapont Life Sciences: Internal Control Audit Report
Huapont Life Sciences: 2023 ANNUAL REPORT
Huapont Life Sciences: 2023 Financial Results Report
Huapont Life Sciences: 2023 Annual Audit Report
Huapont Life Sciences: 2023 Annual Report Summary
Huapont Life Sciences: Independent Director's 2023 Debriefing Report - Liu Zhonghai
No Data